Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
Pacira BioSciences (PCRX) will participate in a fireside chat at the 2024 Jefferies Global Healthcare Conference on June 6, 2024, at 11:00 AM ET in New York.
The chat will be led by an analyst, and a live audio stream will be available on the company's website under the 'Events' section. A replay of the webcast will also be accessible for two weeks after the event.
- Participation in the prestigious 2024 Jefferies Global Healthcare Conference could increase visibility and investor interest for Pacira BioSciences (PCRX).
- A live audio stream and replay availability enhance transparency and provide broader accessibility to the event.
- The press release lacks specific new financial or clinical data, which may disappoint investors seeking substantial updates.
- No immediate business development or partnership announcements, potentially indicating a lack of significant short-term growth catalysts.
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
FAQ
When will Pacira BioSciences participate in the 2024 Jefferies Global Healthcare Conference?
How can I access the live audio of Pacira BioSciences' fireside chat at the 2024 Jefferies Global Healthcare Conference?
Will there be a replay available for Pacira BioSciences' fireside chat at the 2024 Jefferies Global Healthcare Conference?
What is the stock symbol for Pacira BioSciences?
